losartan and exudates

losartan has been researched along with exudates in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burke, TA; Carides, GW; Chan, J; Choi, YJ; Han, DC; Hwang, SJ; Seng, WK; Teong, CC	1
Ismail, SB; Naing, L; Rahman, AR; Rehman, A; Roshan, TM	1

Trials

2 trial(s) available for losartan and exudates

Article	Year
Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective. Nephrology (Carlton, Vic.), 2005, Volume: 10, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Costs; Health Care Costs; Hong Kong; Humans; Hypertension, Renal; Kidney Failure, Chronic; Korea; Losartan; Malaysia; Singapore; Taiwan	2005
Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile. American journal of hypertension, 2007, Volume: 20, Issue:2 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Double-Blind Method; Female; Humans; Hypertension; Losartan; Malaysia; Male; Perindopril; Polymorphism, Genetic; Pulse; Receptor, Angiotensin, Type 1	2007

Article

Year

Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective.

Nephrology (Carlton, Vic.), 2005, Volume: 10, Issue:5

Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Costs; Health Care Costs; Hong Kong; Humans; Hypertension, Renal; Kidney Failure, Chronic; Korea; Losartan; Malaysia; Singapore; Taiwan

2005

Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile.

American journal of hypertension, 2007, Volume: 20, Issue:2

Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Double-Blind Method; Female; Humans; Hypertension; Losartan; Malaysia; Male; Perindopril; Polymorphism, Genetic; Pulse; Receptor, Angiotensin, Type 1

2007